|
NUVL | Nuvalent, Inc. |
|
|
NUVL | Nuvalent, Inc. |
| Pharmaceutical Preparations |
| Book value per $ invested | $ 0.63 |
| Leverage | 7.04% |
| Market Cap | $ 5.0B |
| PE | 0.00 |
| Dividend Yield | 0.00% |
| Profit | $ -300.0m |
| Margin | -1354.65% |
None